ADN Telecom Limited (DSE:ADNTEL)

CTI BioPharma Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	4,946	6,407	8,515	4,254	3,207	2,075
Market Cap Growth	-29.59%	-24.75%	100.15%	32.66%	54.52%	-
Enterprise Value	5,212	6,654	8,470	4,208	3,006	1,684
Last Close Price	76.50	97.92	128.52	63.38	47.01	29.51
PE Ratio	29.59	42.87	32.98	25.38	19.33	12.85
PS Ratio	2.73	4.25	6.32	3.68	2.81	1.84
PB Ratio	2.35	3.15	4.31	2.39	1.91	1.27
P/TBV Ratio	2.45	3.29	4.35	2.39	1.91	1.27
P/FCF Ratio	19.82	-	1036.35	264.08	228.16	-
P/OCF Ratio	11.07	16.64	51.21	20.07	23.61	11.50
EV/Sales Ratio	2.88	4.42	6.29	3.64	2.63	1.49
EV/EBITDA Ratio	13.12	18.52	21.19	15.22	11.53	6.52
EV/EBIT Ratio	17.55	28.11	27.00	21.97	16.11	10.71
EV/FCF Ratio	20.89	-	1030.90	261.21	213.88	-
Debt / Equity Ratio	0.23	0.26	0.14	0.16	0.09	0.08
Debt / EBITDA Ratio	1.17	1.29	0.62	0.89	0.52	0.49
Debt / FCF Ratio	1.92	-	33.45	17.27	11.13	-
Asset Turnover	0.55	0.50	0.51	0.47	0.50	0.60
Inventory Turnover	185.80	148.47	-	-	-	-
Quick Ratio	1.63	1.45	2.23	1.87	1.92	2.14
Current Ratio	2.09	2.06	2.98	2.41	2.40	2.62
Return on Equity (ROE)	8.29%	7.52%	13.73%	9.69%	10.02%	12.53%
Return on Assets (ROA)	5.91%	4.95%	7.38%	4.89%	5.10%	5.24%
Return on Capital (ROIC)	7.66%	6.15%	9.10%	6.15%	6.49%	6.97%
Return on Capital Employed (ROCE)	11.60%	9.10%	13.50%	9.30%	9.90%	8.70%
Earnings Yield	3.38%	2.33%	3.03%	3.94%	5.17%	7.78%
FCF Yield	5.04%	-0.26%	0.10%	0.38%	0.44%	-1.14%
Dividend Yield	1.31%	1.02%	1.17%	1.58%	2.13%	5.08%
Payout Ratio	46.22%	64.94%	24.98%	38.46%	58.20%	0.41%
Buyback Yield / Dilution	-	-	-	-	-14.39%	-
Total Shareholder Return	1.31%	1.02%	1.17%	1.58%	-12.26%	5.08%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.